The system is both radiolucent and radio visible for intra-operative and post-operative imaging. Credit: Dr Manuel González Reyes from Pixabay.

HAPPE Spine has received 510(k) clearance from the US Food and Drug Administration (FDA) for its INTEGRATE-C interbody fusion system.

INTEGRATE-C, which is powered by the Hydroxyapatite Porous Polyetheretherketone (HAPPE) platform, is claimed to be the first interbody fusion cage that is wholly integrated with porosity and hydroxyapatite to provide a better healing environment.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The interconnected and cancellous porosity facilitates the ingrowth of bone from endplate to endplate. The system is both radiolucent and radio visible for intra-operative and post-operative imaging.

Beacon Health System neurosurgeon Dr Stephen Smith said: “Our team at HAPPE is proud and excited to share this advancement with our colleagues. We have achieved our goal of developing an ACDF that’s distinguished from all other existing devices used for interbody fusion.

“The HAPPE INTEGRATE-C delivers superior radiographic visibility, optimum biomechanical properties for both load bearing and healing and true graft incorporation.”

The INTEGRATE-C system provides various sizes and lordotic angles to meet the anatomical requirements of the patients.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Currently, the firm’s commercialisation strategy is focused on a limited user release to validate the product’s efficacy through clinical data.

HAPPE Spine CEO Andrew Iott said: “We are very excited to have gained 510(k) clearance for HAPPE’s new innovative technology and look forward to launching game-changing product solutions in the near future.

“The combination of cancellous porosity with hydroxyapatite exposed on all pore surfaces represents a true leap forward in interbody fusion devices.”

HAPPE Spine is engaged in the designing and commercialisation of advanced orthopaedic and spinal implants using its patented HAPPEmaterial platform.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact